Division of Cardiology, Department of Pediatrics, Herma Heart Institute, Children's Hospital of Wisconsin, Milwaukee, WI, USA.
Business Intelligence and Warehousing, Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI, USA.
Cardiol Young. 2023 May;33(5):704-709. doi: 10.1017/S1047951122001512. Epub 2022 May 18.
Neonatal enteroviral myocarditis is a rare but potentially fatal illness. We sought to identify echocardiographic markers at diagnosis that could help risk-stratify infants for poor outcome and to characterise late sequelae.
We reviewed data for infants <30 days of age diagnosed with enteroviral myocarditis between 1999 and 2019 at Children's Wisconsin. Echo measures were collected retrospectively from the initial neonatal study including left ventricular ejection fraction, shortening fraction, diastolic and systolic dimensions, and peak global circumferential and longitudinal strain.
Fourteen neonates were diagnosed at an average age of 11 days. All had abnormal left ventricular ejection fraction (mean 38%; range 22-53%) at diagnosis. Three infants died, and one required transplantation during initial hospital. The 10 transplant-free survivors had significantly better global circumferential strain and global longitudinal strain at the initial echo compared to the 4 who died or needed transplant (global circumferential strain -13.2% versus -6.8%, p = 0.005; global longitudinal strain -8.8% versus -4.7%, p = 0.016). All other measures of left ventricular systolic function/dimensions were similar between the two groups. Follow-up data were available for 8/10 survivors; 5/8 had a persistently abnormal echo at an average interval of 8.3 years. 4/8 developed a left ventricular aneurysm that was consistently localised to the posterior basal wall.
Neonatal enteroviral myocarditis carries a high risk of early mortality and late morbidity. Echo-derived left ventricular strain measures have utility in risk stratifying infants with enteroviral myocarditis. Most survivors continue to have late dysfunction necessitating cardiology surveillance and medical therapy.
新生儿肠道病毒性心肌炎是一种罕见但潜在致命的疾病。我们试图确定诊断时的超声心动图标志物,以帮助对预后不良的婴儿进行风险分层,并描述后期的后遗症。
我们回顾了 1999 年至 2019 年间在威斯康星儿童医院(Children's Wisconsin)诊断为肠道病毒性心肌炎的<30 天龄婴儿的数据。从最初的新生儿研究中回顾性收集了超声心动图指标,包括左心室射血分数、缩短分数、舒张和收缩尺寸以及峰值整体周向和纵向应变。
14 名婴儿在平均 11 天大时被诊断出患有肠道病毒性心肌炎。所有婴儿在诊断时均存在左心室射血分数异常(平均 38%,范围为 22%-53%)。3 名婴儿死亡,1 名在初始住院期间需要移植。10 名无移植存活者的初始超声心动图的整体周向应变和整体纵向应变明显优于死亡或需要移植的 4 名婴儿(整体周向应变-13.2%比-6.8%,p=0.005;整体纵向应变-8.8%比-4.7%,p=0.016)。两组之间的其他左心室收缩功能/尺寸的测量值相似。8 名存活者中有 5 名有随访数据,平均间隔 8.3 年后,5 名中有 4 名仍存在异常超声心动图。4 名中有 4 名发生了左心室瘤,且均位于基底后侧壁。
新生儿肠道病毒性心肌炎早期死亡率高,后期发病率高。超声心动图衍生的左心室应变指标在对肠道病毒性心肌炎患儿进行风险分层方面具有一定的作用。大多数存活者仍有后期功能障碍,需要进行心脏病学监测和药物治疗。